- King Pharmaceuticals (KG) was acquired by Pfizer Inc. (NYSE: PFE) for $3.6 billion in cash or $14.25 per share. (October 12, 2010)
King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal health products.| Headquarters:501 Fifth Street Bristol, TN 37620 | |
| Web Address:http://www.kingpharm.com |
No comments:
Post a Comment